FIRSOCOSTAT

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C28H31N3O8S
Molecular Weight	569.626
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

COC1=C(C=CC=C1)[C@H](CN2C3=C(C(C)=C(S3)C4=NC=CO4)C(=O)N(C2=O)C(C)(C)C(O)=O)OC5CCOCC5

InChI

InChIKey=ZZWWXIBKLBMSCS-FQEVSTJZSA-N

InChI=1S/C28H31N3O8S/c1-16-21-24(32)31(28(2,3)26(33)34)27(35)30(25(21)40-22(16)23-29-11-14-38-23)15-20(39-17-9-12-37-13-10-17)18-7-5-6-8-19(18)36-4/h5-8,11,14,17,20H,9-10,12-13,15H2,1-4H3,(H,33,34)/t20-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C28H31N3O8S
Molecular Weight	569.626
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

C_max

Value	Dose	Analyte	Population
16.5 ng/mL CLINICAL TRIAL https://accp1.onlinelibrary.wiley.com/doi/epdf/10.1002/jcph.2206	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
15.7 ng/mL CLINICAL TRIAL https://accp1.onlinelibrary.wiley.com/doi/epdf/10.1002/jcph.2206	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
50.9 ng/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
25.4 ng/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
197.7 ng/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
20.1 ng/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
73.8 ng/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	5 mg single, oral dose: 5 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
3 ng/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	5 mg single, oral dose: 5 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED

AUC

Value	Dose	Analyte	Population
53.7 ng × h/mL CLINICAL TRIAL https://accp1.onlinelibrary.wiley.com/doi/epdf/10.1002/jcph.2206	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
80.3 ng × h/mL CLINICAL TRIAL https://accp1.onlinelibrary.wiley.com/doi/epdf/10.1002/jcph.2206	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
165.2 ng × h/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
70.5 ng × h/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
686.6 ng × h/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
65.8 ng × h/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
313.6 ng × h/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	5 mg single, oral dose: 5 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
10.6 ng × h/mL CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	5 mg single, oral dose: 5 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED

T_1/2

Value	Dose	Analyte	Population
6.7 h CLINICAL TRIAL https://accp1.onlinelibrary.wiley.com/doi/epdf/10.1002/jcph.2206	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
14.2 h CLINICAL TRIAL https://accp1.onlinelibrary.wiley.com/doi/epdf/10.1002/jcph.2206	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
5.23 h CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
3.32 h CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
12.82 h CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
3.28 h CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
8.51 h CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	5 mg single, oral dose: 5 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
2.49 h CLINICAL TRIAL https://classic.clinicaltrials.gov/ct2/show/results/NCT02891408	5 mg single, oral dose: 5 mg route of administration: Oral experiment type: SINGLE co-administered:	FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED

F_unbound

Value	Dose	Co-administered	Analyte	Population
4.34% CLINICAL TRIAL https://accp1.onlinelibrary.wiley.com/doi/epdf/10.1002/jcph.2206	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:		FIRSOCOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
3.44% CLINICAL TRIAL https://accp1.onlinelibrary.wiley.com/doi/epdf/10.1002/jcph.2206	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:		FIRSOCOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED

Substance Class	Chemical Created by `admin` on `Tue Apr 01 21:11:18 GMT 2025` Edited by `admin` on `Tue Apr 01 21:11:18 GMT 2025`
Record UNII	XE10NJQ95M
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FIRSOCOSTAT

Official Name

English

GS-0976

Preferred Name

English

FIRSOCOSTAT [USAN]

Common Name

English

Firsocostat [WHO-DD]

Common Name

English

ND-630

Code

English

NDI-010976

Common Name

English

THIENO(2,3-D)PYRIMIDINE-3(2H)-ACETIC ACID, 1,4-DIHYDRO-1-((2R)-2-(2-METHOXYPHENYL)-2-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)ETHYL)-.ALPHA.,.ALPHA.,5-TRIMETHYL-6-(2-OXAZOLYL)-2,4-DIOXO-

Systematic Name

English

1,4-DIHYDRO-1-((2R)-2-(2-METHOXYPHENYL)-2-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)ETHYL)-.ALPHA.,.ALPHA.,5-TRIMETHYL-6-(2-OXAZOLYL)-2,4-DIOXOTHIENO(2,3-D)PYRIMIDINE-3(2H)-ACETIC ACID

Systematic Name

English

firsocostat [INN]

Common Name

English

GS-ACC

Code

English

Code System Code Type Description

FDA UNII

XE10NJQ95M